文献速递心律失常血脂与心血管预防

衰老与新发合并症对房颤患者卒中风险的动态影响:ΔCHA2DS2-VASc评分

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

本研究基于31,039例未接受抗血小板或口服抗凝药、除年龄和性别外无CHA2DS2-VASc合并症的房颤患者,提出ΔCHA2DS2-VASc评分(基线与随访评分差值)。随访171,956人年期间4,103例发生缺血性卒中,ΔCHA2DS2-VASc评分对卒中的预测优于基线或随访评分,提示房颤卒中风险是随年龄和合并症增加而动态变化的过程。

要点

  • 房颤患者卒中风险非静态,随访中评分常增加。
  • ΔCHA2DS2-VASc评分较基线或随访评分更能预测缺血性卒中。
  • 多数卒中患者在事件前已出现至少1个新发卒中危险因素。

核心结论

  • 房颤患者CHA2DS2-VASc评分非静态,多数患者在缺血性卒中前出现至少1个新发危险因素。
  • ΔCHA2DS2-VASc评分反映基线与随访间评分变化,对缺血性卒中具有强预测价值。

研究设计与样本

  • 研究纳入31,039例房颤患者,均未接受抗血小板药或口服抗凝药,且除年龄和性别外无CHA2DS2-VASc合并症。
  • ΔCHA2DS2-VASc评分定义为基线与随访CHA2DS2-VASc评分的差值。
  • 随访共171,956人年,4,103例发生缺血性卒中,比较基线、随访和ΔCHA2DS2-VASc评分的预测准确性。

主要发现

  • 基线CHA2DS2-VASc评分平均1.29,随访期间增至2.31,平均ΔCHA2DS2-VASc评分为1.02。
  • 仅40.8%患者CHA2DS2-VASc评分保持不变。
  • 4,103例缺血性卒中患者中89.4%的ΔCHA2DS2-VASc评分≥1,而无缺血性卒中患者中仅54.6%。
  • 2,643例(64.4%)患者发生至少1个新发合并症,最常见为高血压。
  • ΔCHA2DS2-VASc评分是缺血性卒中的显著预测因子,经C指数和净重分类指数评估优于基线或随访评分。

临床怎么用

  • 临床应动态评估房颤患者卒中风险,关注年龄增长和新发合并症导致的评分变化。
  • ΔCHA2DS2-VASc评分可能有助于识别随访期间卒中风险升高的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: When assessing ischemic stroke risk in patients with atrial fibrillation (AF), the CHA2DS2-VASc score is calculated based on the baseline risk factors, and the outcomes are determined after a follow-up period. However, the stroke risk in patients with AF does not remain static, and with time, patients get older and accumulate more comorbidities. OBJECTIVES: This study hypothesized that the "Delta CHA2DS2-VASc score," which reflects the change in score between baseline and follow-up, would be more predictive of ischemic stroke compared with the baseline CHA2DS2-VASc score. METHODS: A total of 31,039 patients with AF who did not receive antiplatelet agents or oral anticoagulants, and who did not have comorbidities of the CHA2DS2-VASc score except for age and sex, were studied. The Delta CHA2DS2-VASc scores were defined as the differences between the baseline and follow-up CHA2DS2-VASc scores. During 171,956 person-years, 4,103 patients experienced ischemic stroke. The accuracies of baseline, follow-up, and Delta CHA2DS2-VASc scores in predicting ischemic stroke were analyzed and compared. RESULTS: The mean baseline CHA2DS2-VASc score was 1.29, which increased to 2.31 during the follow-up, with a mean Delta CHA2DS2-VASc score of 1.02. The CHA2DS2-VASc score remained unchanged in only 40.8% of patients. Among 4,103 patients who experienced ischemic stroke, 89.4% had a Delta CHA2DS2-VASc score ≥1 compared with only 54.6% in patients without ischemic stroke, and 2,643 (64.4%) patients had ≥1 new-onset comorbidity, the most common being hypertension. The Delta CHA2DS2-VASc score was a significant predictor of ischemic stroke that performed better than baseline or follow-up CHA2DS2-VASc scores, as assessed by the C-index and the net reclassification index. CONCLUSIONS: In this AF cohort, the authors demonstrated that the CHA2DS2-VASc score was not static, and that most patients with AF developed ≥1 new stroke risk factor before presentation with ischemic stroke. The Delta CHA2DS2-VASc score, reflecting the change in score between baseline and follow-up, was strongly predictive of ischemic stroke, reflecting how stroke risk in AF is a dynamic process due to increasing age and incident comorbidities.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Chao TF, Lip GYH, Liu CJ, et al. Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2018. PMID: 29325634. doi:10.1016/j.jacc.2017.10.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。